Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000150630 | SCV000197955 | drug response | Tyrosine kinase inhibitor response | 2006-10-28 | no assertion criteria provided | clinical testing | |
Database of Curated Mutations |
RCV000428294 | SCV000504241 | pathogenic | Non-small cell lung carcinoma | 2014-10-02 | no assertion criteria provided | literature only | |
Database of Curated Mutations |
RCV000438538 | SCV000504242 | likely pathogenic | Squamous cell lung carcinoma | 2016-05-31 | no assertion criteria provided | literature only | |
Database of Curated Mutations |
RCV000420876 | SCV000504243 | likely pathogenic | Lung adenocarcinoma | 2016-05-31 | no assertion criteria provided | literature only | |
Key Laboratory of Carcinogenesis and Cancer Invasion, |
RCV000420876 | SCV004042725 | likely pathogenic | Lung adenocarcinoma | no assertion criteria provided | clinical testing |